Poseida Therapeutics, Inc. Current Assets
Poseida Therapeutics, Inc. had Current Assets of $250.70 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2024-11-07
- 2024-09-30: Assets, Current $250.70M.
- 2024-06-30: Assets, Current $254.34M.
- 2024-03-31: Assets, Current $216.73M.
- 2023-12-31: Assets, Current $226.47M.
| Period end | Assets, Current |
|---|---|
| 2024-09-30 | $250.70M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $254.34M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $216.73M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $226.47M 10-Q · filed 2024-11-07 |
| 2023-09-30 | $252.66M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $230.19M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $260.70M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $298.56M 10-K · filed 2024-03-07 |
| 2022-09-30 | $325.13M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $148.12M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $190.51M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $213.87M 10-K · filed 2023-03-09 |
| 2021-09-30 | $204.80M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $240.37M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $274.00M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $314.00M 10-K · filed 2022-03-10 |
| 2020-09-30 | $347.28M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $173.15M 10-Q · filed 2020-08-20 |
| 2019-12-31 | $127.18M 10-K · filed 2021-03-11 |